Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to BCG
Related studies linked through entity extraction aliases.
A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder
- Status
- TERMINATED
- Phase
- PHASE2
MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dose-escalation Safety and Immunogenicity Study to Compare MTBVAC to BCG in Newborns With a Safety Arm in Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Aerosol BCG Challenge Trial in Healthy UK Adults
- Status
- COMPLETED
- Phase
- PHASE1
Leukapheresis Sampling for Immune Responses After BCG Vaccination in BCG-naïve Healthy Adults in the US
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Study to Evaluate the Safety and Immunogenicity of VPM1002 in Comparison With BCG in HIV-exposed/-Unexposed Newborn Infants in South Africa
- Status
- COMPLETED
- Phase
- PHASE2
Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 on Healthy People Aged 18-65
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity Study of BCG, H4:IC31, and H56:IC31 Revaccination in Healthy Adolescents
- Status
- COMPLETED
- Phase
- PHASE1
Role of BCG as Booster Vaccination
- Status
- COMPLETED
- Phase
- NA
Effects of BCG on Influenza Induced Immune Response
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase I Trial of DAR-901
- Status
- COMPLETED
- Phase
- PHASE1
Early Versus Delayed BCG Vaccination of HIV-exposed Infants
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Randomized Trial of Providing BCG Vaccination Immediately
- Status
- TERMINATED
- Phase
- PHASE4
Melbourne Infant Study - Bacille Calmette Guérin (BCG) for Allergy & Infection Reduction
- Status
- COMPLETED
- Phase
- PHASE3
BCG Modulation of the recMAGE-A3 + AS15 ASCI Response in the Treatment of Non Muscle Invasive Bladder Cancer (NMIBC) Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study to Evaluate Safety and Immunogenicity of VPM1002 in Comparison With BCG in Newborn Infants in South Africa
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Immunogenicity of GSK Biologicals' Malaria Vaccine 257049 When Administered on 7 Schedules to African Infants
- Status
- COMPLETED
- Phase
- PHASE2
Dose-Escalation Study on Safety and Immunogenicity of VPM1002 in Comparison With BCG in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1